A new, shorter drug regimen to treat certain types of Hepatitis C was found to be as effective as the current, longer treatment, according to the findings of a large multi-center trial published in the New England Journal of Medicine.
Patients with an advanced form of kidney cancer have similar quality of life outcomes on a therapy called cabozantinib, compared to those on a standard treatment.
An emergency thrombectomy, which surgically removes large blood clots, may be beneficial in far more stroke patients than previously thought, according to a new trial.
An emergency department program focused on geriatric transitional care has reduced the risk of unnecessary admission of older patients at Northwestern Medicine by 33 percent.
Scientists have developed an algorithm that uses brain scans to predict language ability in deaf children after they receive a cochlear implant.
Georges Bordage, MD, MSc, PhD, professor of Medical Education at the University of Illinois at Chicago, delivered a talk on diagnostic reasoning and how to teach it to trainees.
Under the leadership of Lee Lindquist, MD, Northwestern is expanding its role in offering home-based primary care for seniors, including a new training program for providers.
A Northwestern Medicine clinical trial found that a stem cell therapy did not improve walking ability in people with peripheral artery disease, although exercise did lead to significant improvements.
The 7th Annual Les Turner Symposium showcased the integration of ALS investigation and clinical care at Northwestern Medicine and the Les Turner ALS Foundation.
Patients with advanced neuroendocrine tumors had a similar quality of life while on a newly approved chemotherapy drug, as compared to patients receiving a placebo, according to a Northwestern Medicine study.